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Hypertension is one the most prevalent risk factors worldwide, especially in patients with established cardiovascular disease. Nevertheless, blood 
pressure control is usually reported to be quite poor in patients with and without cardiovascular disase. We assessed changes in prevalence, control 
and guidelines implementation in 2 nationwide registries performed in 1999 and 2009.
Methods:  Through november 2009 25,137 patients were collected and were compared by percentajes variance equation with the 32,051 
collected in 1999. Patients were collected from primary care practitioners (88.4%) and cardiology outpatient clinics.
Results:  The overall prevalence of hypertension increased 23% (23% to 30%; p<0.01). The prevalence of hypertension in patients with heart 
failure increased 16.5% (77% to 89.7%; p<0.01), 30.1% in patients with coronary heart disease (66% to 85.9%; p<0.01) and 33.2% in patients 
with atrial fibrillation (66% to 87.9%; p<0.01). The overall control of blood pressure increased 26.5% (40 to 55%; p<0.01) and 60% in patients 
with established cardiovascular disease (20 to 32%; p<0.01). The use of betablockers, angiotensin-convertor enzyme inhibitors (ACEI), angiotensin 
receptor blockers (ARB) and calcium channel blockers increased (p<0.01) and only diuretics dicreased (p<0.01). Patients with hypertension and 
heart failure experimented a 82.3% increase in treatment with ACEI or ARB (47% to 82.3%; p<0.01); a relevant increase in betablockers treatment 
was also observerd in hypertensive patients with coronary heart (32% to 57.7%; p<0.01; 80% increase).
Conclusions:  Prevalence of hypertension has increased through last decade both in patients with and without cardiovascular disease. 
Hypertension control and guidelines complementation has improved through last decade.
